|2.96||-0.33 / -10.03%|
As of 4:00pm ET
|2.96||+0.0006 / +0.02%|
The 7 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 12.00, with a high estimate of 15.00 and a low estimate of 11.00. The median estimate represents a +305.41% increase from the last price of 2.96.
The current consensus among 8 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.